Literature DB >> 19915932

Establishment and characterization of human bladder cancer cell lines BexBra1, BexBra2, and BexBra4.

Camila B Piantino1, Juliana M Sousa-Canavez, Victor Srougi, Fernanda Salvadori, Raphael Kato, Pedro Paulo R Ayres, Miguel Srougi, Luiz Heraldo Camara-Lopes, Gilka Jorge Figaro Gattás, Cintia Fridman, Fernanda de Toledo, Isaque Santana, Kátia Ramos Moreira Leite.   

Abstract

Bladder cancer (BC) is the fourth most common cancer in the USA. In Brazil, BC represents 3% of the total existing carcinomas in the population and represents the second highest incidence among urological tumors. The majority of bladder cancer cell lines available were derived from Caucasians and established in the seventies or eighties. Thus, neoplasia development in these cells likely occurred in environment conditions vastly different than today. In the present study, we report the establishment and characterization of three Brazilian bladder cancer cell lines (BexBra1, BexBra2, and BexBra4). These cell lines may be helpful for dissecting the genetic and epigenetic aspects that trigger the progression of BC. Moreover, the development of a Brazilian representative of the disease will allow us to investigate the potential inter-racial differences of malignancy-associated phenotypes in bladder cancer.

Entities:  

Mesh:

Year:  2010        PMID: 19915932     DOI: 10.1007/s11626-009-9252-z

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  20 in total

Review 1.  Genetic markers as tracers in cell culture.

Authors:  S M Gartler
Journal:  Natl Cancer Inst Monogr       Date:  1967-09

Review 2.  Human cancer cell lines: fact and fantasy.

Authors:  J R Masters
Journal:  Nat Rev Mol Cell Biol       Date:  2000-12       Impact factor: 94.444

3.  Curcumin inhibits activation of Vgamma9Vdelta2 T cells by phosphoantigens and induces apoptosis involving apoptosis-inducing factor and large scale DNA fragmentation.

Authors:  B Cipriani; G Borsellino; H Knowles; D Tramonti; F Cavaliere; G Bernardi; L Battistini; C F Brosnan
Journal:  J Immunol       Date:  2001-09-15       Impact factor: 5.422

Review 4.  Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification.

Authors:  Anirban P Mitra; Ram H Datar; Richard J Cote
Journal:  J Clin Oncol       Date:  2006-12-10       Impact factor: 44.544

5.  Retinoblastoma protein expression and radiation response in muscle-invasive bladder cancer.

Authors:  A Pollack; B Czerniak; G K Zagars; S X Hu; C S Wu; C P Dinney; V Chyle; W F Benedict
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-10-01       Impact factor: 7.038

6.  Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound.

Authors:  Vladimir J N Bykov; Natalia Issaeva; Alexandre Shilov; Monica Hultcrantz; Elena Pugacheva; Peter Chumakov; Jan Bergman; Klas G Wiman; Galina Selivanova
Journal:  Nat Med       Date:  2002-03       Impact factor: 53.440

Review 7.  Therapeutic approaches to bladder cancer: identifying targets and mechanisms.

Authors:  Richard J Cote; Ram H Datar
Journal:  Crit Rev Oncol Hematol       Date:  2003-06-27       Impact factor: 6.312

8.  FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder.

Authors:  Ashraf A Bakkar; Herve Wallerand; François Radvanyi; Jean-Baptiste Lahaye; Serge Pissard; Laure Lecerf; Jean Claude Kouyoumdjian; Claude C Abbou; Jean-Claude Pairon; Marie-Claude Jaurand; Jean-Paul Thiery; Dominique K Chopin; Sixtina Gil Diez de Medina
Journal:  Cancer Res       Date:  2003-12-01       Impact factor: 12.701

9.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

10.  Alterations of TP53 in microdissected transitional cell carcinoma of the human urinary bladder: high frequency of TP53 accumulation in the absence of detected mutations is associated with poor prognosis.

Authors:  R Abdel-Fattah; C Challen; T R Griffiths; M C Robinson; D E Neal; J Lunec
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

View more
  2 in total

1.  Characterization of three newly established rat sarcoma cell clones.

Authors:  Monika Holubova; Martin Leba; Markéta Sedmikova; Luca Vannucci; Vratislav Horak
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-11-13       Impact factor: 2.416

2.  Classification of bladder cancer cell lines according to regulon activity.

Authors:  Aleyna Eray; Serap Erkek-Özhan
Journal:  Turk J Biol       Date:  2021-12-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.